Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Bio Essence (BIOE) Shares Outstanding (Diluted Average) (2021 - 2024)

Bio Essence (BIOE) has 4 years of Shares Outstanding (Diluted Average) data on record, last reported at $38.0 million in Q2 2024.

  • For Q2 2024, Shares Outstanding (Diluted Average) rose 9.5% year-over-year to $38.0 million; the TTM value through Jun 2024 reached $38.0 million, up 9.5%, while the annual FY2023 figure was $36.0 million, 8.92% up from the prior year.
  • Shares Outstanding (Diluted Average) reached $38.0 million in Q2 2024 per BIOE's latest filing, roughly flat from $38.0 million in the prior quarter.
  • Across five years, Shares Outstanding (Diluted Average) topped out at $38.0 million in Q1 2024 and bottomed at $33.0 million in Q2 2021.
  • Average Shares Outstanding (Diluted Average) over 4 years is $34.3 million, with a median of $33.0 million recorded in 2021.
  • Peak YoY movement for Shares Outstanding (Diluted Average): changed 0.0% in 2022, then rose 15.15% in 2024.
  • A 4-year view of Shares Outstanding (Diluted Average) shows it stood at $33.0 million in 2021, then changed by 0.0% to $33.0 million in 2022, then grew by 8.92% to $36.0 million in 2023, then rose by 5.72% to $38.0 million in 2024.
  • Per Business Quant database, its latest 3 readings for Shares Outstanding (Diluted Average) were $38.0 million in Q2 2024, $38.0 million in Q1 2024, and $36.0 million in Q4 2023.